4.5 hours: the new time window for tissue plasminogen activator in stroke

Stroke. 2009 Jun;40(6):2266-7. doi: 10.1161/STROKEAHA.108.544171. Epub 2009 Apr 30.
No abstract available

MeSH terms

  • Acute Disease
  • Cerebral Hemorrhage / complications
  • Clinical Trials, Phase III as Topic
  • Fibrinolytic Agents / therapeutic use*
  • Guidelines as Topic
  • Humans
  • Randomized Controlled Trials as Topic
  • Stroke / drug therapy*
  • Stroke / etiology
  • Thrombolytic Therapy / standards*
  • Thrombolytic Therapy / statistics & numerical data
  • Time Factors
  • Tissue Plasminogen Activator / therapeutic use*

Substances

  • Fibrinolytic Agents
  • Tissue Plasminogen Activator